A wide range of biomedical devices
are being used to treat cardiovascular
diseases, and thus they routinely come into contact with blood. Insufficient
hemocompatibility has been found to impair the functionality and safety
of these devices through the activation of blood coagulation and the
immune system. Numerous attempts have been made to develop surface
modification approaches of the cardiovascular devices to improve their
hemocompatibility. However, there are still no ideal “blood-friendly”
coating materials, which possess the desired hemocompatibility, tissue
compatibility, and mechanical properties. As a novel multifunctional
material, graphene has been proposed for a wide range of biomedical
applications. The chemical inertness, atomic smoothness, and high
durability make graphene an ideal candidate as a surface coating material
for implantable devices. Here, we evaluated the hemocompatibility
of a graphene film prepared on quartz glasses (Gra-glasses) from a
direct chemical vapor deposition process. We found that the graphene
coating, which is free of transfer-mediating polymer contamination,
significantly suppressed platelet adhesion and activation, prolonged
coagulation time, and reduced ex vivo thrombosis
formation. We attribute the excellent antithrombogenic properties
of the Gra-glasses to the low surface roughness, low surface energy
(especially the low polar component of the surface energy), and the
negative surface charge of the graphene film. Given these excellent
hemocompatible properties, along with its chemical inertness, high
durability, and molecular impermeability, a graphene film holds great
promise as an antithrombogenic coating for next-generation cardiovascular
devices.